Richard Newitter
Stock Analyst at Truist Securities
(4.41)
# 319
Out of 4,876 analysts
366
Total ratings
55.05%
Success rate
16.17%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Initiates: Hold | $24 | $19.11 | +25.59% | 1 | Jun 16, 2025 | |
| DXCM DexCom | Initiates: Buy | $102 | $85.04 | +19.94% | 1 | Jun 16, 2025 | |
| PODD Insulet | Initiates: Buy | $365 | $309.83 | +17.81% | 1 | Jun 16, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $26 | $14.99 | +73.45% | 1 | Jun 16, 2025 | |
| GMED Globus Medical | Maintains: Hold | $80 → $68 | $58.82 | +15.61% | 27 | May 12, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $127 → $117 | $80.74 | +44.91% | 18 | May 8, 2025 | |
| TFX Teleflex | Maintains: Hold | $140 → $137 | $119.58 | +14.57% | 38 | May 5, 2025 | |
| SYK Stryker | Maintains: Hold | $390 → $400 | $390.40 | +2.46% | 20 | May 5, 2025 | |
| GKOS Glaukos | Reiterates: Buy | $140 → $135 | $101.06 | +33.58% | 5 | May 1, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $140 → $150 | $121.87 | +23.08% | 7 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $117 | $104.58 | +11.88% | 12 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $605 → $590 | $534.19 | +10.45% | 28 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $70 | $58.63 | +19.39% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $51 | $41.66 | +22.42% | 3 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9.5 → $8 | $5.59 | +43.11% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $90 | $86.18 | +4.43% | 15 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $21.77 | +10.24% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $12.21 | +55.61% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $78 → $75 | $77.15 | -2.79% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $152.69 | -5.04% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $235 | $129.71 | +81.17% | 24 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $91.74 | +23.17% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $253.58 | +12.39% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $18.09 | +16.09% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.23 | +51.17% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $87.11 | -5.87% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $169.97 | +47.08% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $3.61 | +620.22% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $187.74 | +310.14% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $65.11 | +30.55% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.60 | +58.73% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $10.47 | +157.88% | 5 | Feb 23, 2021 |
Tandem Diabetes Care
Jun 16, 2025
Initiates: Hold
Price Target: $24
Current: $19.11
Upside: +25.59%
DexCom
Jun 16, 2025
Initiates: Buy
Price Target: $102
Current: $85.04
Upside: +19.94%
Insulet
Jun 16, 2025
Initiates: Buy
Price Target: $365
Current: $309.83
Upside: +17.81%
Beta Bionics
Jun 16, 2025
Initiates: Buy
Price Target: $26
Current: $14.99
Upside: +73.45%
Globus Medical
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $58.82
Upside: +15.61%
Lantheus Holdings
May 8, 2025
Maintains: Buy
Price Target: $127 → $117
Current: $80.74
Upside: +44.91%
Teleflex
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $119.58
Upside: +14.57%
Stryker
May 5, 2025
Maintains: Hold
Price Target: $390 → $400
Current: $390.40
Upside: +2.46%
Glaukos
May 1, 2025
Reiterates: Buy
Price Target: $140 → $135
Current: $101.06
Upside: +33.58%
Integer Holdings
Apr 28, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $121.87
Upside: +23.08%
Apr 24, 2025
Maintains: Buy
Price Target: $113 → $117
Current: $104.58
Upside: +11.88%
Apr 23, 2025
Maintains: Buy
Price Target: $605 → $590
Current: $534.19
Upside: +10.45%
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $58.63
Upside: +19.39%
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $41.66
Upside: +22.42%
Apr 11, 2025
Maintains: Hold
Price Target: $9.5 → $8
Current: $5.59
Upside: +43.11%
Apr 11, 2025
Maintains: Hold
Price Target: $93 → $90
Current: $86.18
Upside: +4.43%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $21.77
Upside: +10.24%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $12.21
Upside: +55.61%
Apr 11, 2025
Maintains: Hold
Price Target: $78 → $75
Current: $77.15
Upside: -2.79%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $152.69
Upside: -5.04%
Feb 11, 2025
Maintains: Buy
Price Target: $250 → $235
Current: $129.71
Upside: +81.17%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $91.74
Upside: +23.17%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $253.58
Upside: +12.39%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $18.09
Upside: +16.09%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $13.23
Upside: +51.17%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $87.11
Upside: -5.87%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $169.97
Upside: +47.08%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $3.61
Upside: +620.22%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $187.74
Upside: +310.14%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $65.11
Upside: +30.55%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.60
Upside: +58.73%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $10.47
Upside: +157.88%